Affiliation:
1. Munich Leukemia Laboratory, Munich, Germany
Abstract
Key Points
TP53 mutations are detected in 15.7% of patients with ALL and are correlated to a low hypodiploid karyotype and to MYC-translocations. Disruption of both TP53 alleles is associated with adverse prognosis in ALL.
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Cited by
118 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献